Myriad Genetics Inc
MYGN· Nasdaq
MYGNMyriad Genetics Inc
Source filing unavailable
| Metric | Q4 2018 | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|---|---|
| Revenue | $216.80M | $173.20M | $189.30M | $188.75M |
| Net Income | $2.60M | $15.30M | $18.40M | $33.61M |
| EPS Diluted | $0.03 | — |
Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR
| — |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
